← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Coare Holdings, Inc.
Oklahoma City, OK
$2,533,098
Total funding
2
Grants
Funding over time
peak $989.8K · FY2018–22$1M$750K$500K$250K$0
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,533,098 · 2
By mechanism
R44$2,533,098 · 2
Investigators at Coare Holdings, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer$989,826
R44 · FY2021 · CA
Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer$945,646
R44 · FY2022 · CA
Pre-IND development of CBT-15 monoclonal antibody therapy against renal cell cancer$298,835
R44 · FY2018 · CA
Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer$298,791
R44 · FY2018 · CA